Secondary safety outcome
The secondary safety outcome of any bleeding events was significantly
lower (7.7% vs. 14.8%; HR, 0.53; 95%CI, 0.32-0.88; P=0.02; Table 3)
in the DAPT group. Fewer patients under the DAPT treatment suffered from
CRNMB (3.2% vs. 8.9%; HR, 0.37; 95%CI, 0.19-0.73; P=0.01; Table 3).
Most of the bleeding events (15/17, 88.2% in the DAPT and 39/45, 86.7%
in the ACT groups) were recorded during the intensified antithrombotic
period.